deCODE genetics Financial Statements
deCODE genetics Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
deCODE genetics Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 40.4 | 40.5 | 44.0 |
| Gross Profit ($ mil.) | (6.6) | (2.2) | 6.7 |
| Operating Income ($ mil.) | (87.6) | (84.5) | (57.2) |
| Total Net Income ($ mil.) | (95.5) | (85.5) | (62.8) |
| Diluted EPS (Net Income) | (1.57) | (1.49) | (1.17) |
deCODE genetics Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 15.0 | 15.0 | 13.3 |
| Gross Profit ($ mil.) | 1.6 | 0.3 | (1.6) |
| Operating Income ($ mil.) | (13.5) | (19.6) | (21.9) |
| Total Net Income ($ mil.) | (18.4) | (26.7) | (32.4) |
| Diluted EPS (Net Income) | (0.29) | (0.44) | (0.54) |
deCODE genetics Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.69 | 1.48 | 1.56 |
| Price/Earnings Ratio | -- | 22.56 | 15.82 |
| Price/Book Ratio | -- | 2.77 | 1.52 |
| Price/Cash Flow Ratio | -- | 14.73 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed deCODE genetics Financial Ratios
deCODE genetics Competitive Intelligence
| Celera | Myriad Genetics | Roche Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 44.2 | 157.1 | 215.1 |
| Employees | 300 | -- | 2,000 |
| Market Cap ($ mil.) | -- | 2,941.2 | -- |
Competitive Landscape
